The u.S.Food and drug administration (fda) is warning the public to stop using the innova medical group sars-cov-2 antigen rapid qualitative test for diagnostic use.The fda has significant concerns that the performance of the test has not been adequately established, presenting a risk to health.In addition to this result prior to me having the sars-cor-2 rt-qpcr test administered to me in (b)(6) 2021 i had an successful ultrasound confirming the records of an fetus with a strong heart beat and in correct position of the placenta having to be a successful growing size to support my (b)(6) pregnancy.I have medical documentation to support the mentioned ultrasound date.Eight days after have taken the nasal test mentioned above on the date of (b)(6) i was rushed to the (b)(6) for medical treatment in response to a spontaneous miscarriage.Medical documentation to support this accident is available for your records.I anticipate a response to my matter in a timely order.Yours truly (b)(6).Fda safety report id # (b)(4).
|